Health News

Jun 16, 2025

Understanding heart treatment outcomes in tiny babies

Explore how closing a heart vessel in preterm infants affects their breathing and blood pressure, and what new research reveals about short-term risks and safety.

Have you ever wondered what happens when doctors need to fix a tiny problem inside the heart of a newborn baby? One of the most common issues in premature babies is called a patent ductus arteriosus (PDA). This is a small blood vessel that should close soon after birth, but sometimes it stays open, making it tough for babies to breathe and for their hearts to work properly. Let's take a closer look at what happens when doctors use a special procedure to close this vessel and how it affects these fragile infants.

What is patent ductus arteriosus (PDA)?

PDA is like a shortcut in the heart that is supposed to close after a baby is born. In some babies, especially those born early, it does not close on its own. This can lead to extra blood flowing to the lungs, causing breathing problems and making the heart work harder. According to scientists, about 10% of all heart defects in babies are due to PDA, and it is even more common in babies weighing less than 1200 grams at birth. Doctors have tried many ways to fix this, but there is still no perfect answer for the tiniest, most fragile infants.

How do doctors close the PDA?

Doctors can use medicine, surgery, or a newer technique called transcatheter PDA closure (TCPC). TCPC is less invasive and uses a small tube and device to close the blood vessel without making a big cut. This method is becoming the top choice in many hospitals, and studies show it is safe and effective (learn more about treatment methods).

What risks do babies face after the procedure?

After surgery or TCPC, some babies may experience trouble with their breathing or blood pressure. This is called post-transcatheter cardiorespiratory syndrome (PTCS). Doctors have found that PTCS is more common after surgery than after TCPC, but it can still happen. Some thought that babies who needed a lot of breathing support before the procedure (measured by something called the respiratory severity score or RSS) would have a higher risk of PTCS. However, a recent study found this is not always true.

What did the latest research find?

A study looked at 46 premature infants who had TCPC and were on breathing machines before the procedure (see the study here). Researchers wanted to see if a higher RSS (meaning more help with breathing) before the procedure made it more likely for a baby to have PTCS or high blood pressure afterward. Surprisingly, they found that having a higher RSS did not mean a baby was more likely to have problems after the procedure. PTCS happened in only about 11% of babies, while high blood pressure was quite common after the procedure, showing up in about 61% of the infants. Most of the time, this high blood pressure was not serious and did not need treatment.

Why do these results matter for families?

If your baby needs TCPC, it can be scary to think about possible complications. The good news from this study is that serious breathing or heart problems after the procedure are not as common as once thought, and they are not linked to how much breathing support a baby needed before the procedure. Even though high blood pressure happens a lot afterward, it usually goes away on its own and does not require medicine.

How do hospitals keep track of these babies?

Doctors use special computer systems to collect and analyze information about each baby’s health before and after the procedure (read about electronic health data). This helps them learn from every case and improve care for future patients. As health AI and platforms like SlothMD become more common, it is important to know how your information is kept safe. For more on how health AI systems protect your data, you can check this explanation about how health AI responds to data breaches.

What’s next in PDA research?

Doctors still have questions. For example, why do so many babies get high blood pressure after TCPC, and does it matter in the long run? Researchers are also working on better ways to predict which babies might have trouble after the procedure, possibly using smarter health AI tools in the future. If you are curious about when technology can help with health decisions, you might enjoy reading about when to trust AI symptom checkers over doctors.

Understanding how procedures like TCPC affect tiny babies helps doctors and families make better choices. Thanks to ongoing research and advances in health AI, care for the smallest patients keeps getting safer and smarter.

Comments

Health News

Jun 16, 2025

How nasopharyngeal cancer hides from the immune system

Scientists have discovered how nasopharyngeal cancer cells use a molecule called miR-155 to hide from the immune system, making treatment harder and affecting cancer immunotherapy success.

Health News

Jun 16, 2025

How nasopharyngeal cancer hides from the immune system

Scientists have discovered how nasopharyngeal cancer cells use a molecule called miR-155 to hide from the immune system, making treatment harder and affecting cancer immunotherapy success.

Health News

Jun 16, 2025

How nasopharyngeal cancer hides from the immune system

Scientists have discovered how nasopharyngeal cancer cells use a molecule called miR-155 to hide from the immune system, making treatment harder and affecting cancer immunotherapy success.

Health News

Jun 16, 2025

Understanding heart treatment outcomes in tiny babies

Explore how closing a heart vessel in preterm infants affects their breathing and blood pressure, and what new research reveals about short-term risks and safety.

Health News

Jun 16, 2025

Understanding heart treatment outcomes in tiny babies

Explore how closing a heart vessel in preterm infants affects their breathing and blood pressure, and what new research reveals about short-term risks and safety.

Health News

Jun 16, 2025

Understanding heart treatment outcomes in tiny babies

Explore how closing a heart vessel in preterm infants affects their breathing and blood pressure, and what new research reveals about short-term risks and safety.

Health News

Jun 16, 2025

A new hope for colorectal cancer with KRAS G12C

Scientists are testing a new medicine, garsorasib, for colorectal cancer that carries the KRAS G12C mutation, showing encouraging results when used alone and even better when combined with another treatment.

Health News

Jun 16, 2025

A new hope for colorectal cancer with KRAS G12C

Scientists are testing a new medicine, garsorasib, for colorectal cancer that carries the KRAS G12C mutation, showing encouraging results when used alone and even better when combined with another treatment.

Health News

Jun 16, 2025

A new hope for colorectal cancer with KRAS G12C

Scientists are testing a new medicine, garsorasib, for colorectal cancer that carries the KRAS G12C mutation, showing encouraging results when used alone and even better when combined with another treatment.

©2025 — 360H, Inc.

*We are not affiliated, associated, or endorsed by any of the companies whose logos appear on this site. Their trademarks are the property of their respective owners, and any mention or depiction is solely for informational purposes.

©2025 — 360H, Inc.

*We are not affiliated, associated, or endorsed by any of the companies whose logos appear on this site. Their trademarks are the property of their respective owners, and any mention or depiction is solely for informational purposes.

SlothMD logo
SlothMD logo
SlothMD logo